Aion Therapeutic Inc (TSE:AION) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Aion Therapeutic, via its subsidiary Toppen Health, has acquired global rights to I2Pure’s patented molecular iodine technology for water disinfection, aiming to enhance its water filtration systems. The innovative technology promises to provide highly effective removal of bacteria, pathogens, and various contaminants, ensuring safer water. The agreement includes a financial arrangement of cash and share payments to I2Pure, along with future royalties.
For further insights into TSE:AION stock, check out TipRanks’ Stock Analysis page.
